Therapeutic Advantage of the Positive Allosteric Modulators of the GABA-B Receptor.
作者信息
Abdel-Magid Ahmed F
机构信息
Therachem Research Medilab (India) Pvt. Ltd., Jaipur, India.
出版信息
ACS Med Chem Lett. 2017 Apr 12;8(5):474-475. doi: 10.1021/acsmedchemlett.7b00149. eCollection 2017 May 11.
Abstract
摘要
相似文献
1
Therapeutic Advantage of the Positive Allosteric Modulators of the GABA-B Receptor.γ-氨基丁酸B受体正性变构调节剂的治疗优势
ACS Med Chem Lett. 2017 Apr 12;8(5):474-475. doi: 10.1021/acsmedchemlett.7b00149. eCollection 2017 May 11.
2
Activation of the γ-Aminobutyric Acid Type B (GABA(B)) Receptor by Agonists and Positive Allosteric Modulators.激动剂和正变构调节剂对γ-氨基丁酸B型（GABA(B)）受体的激活
J Med Chem. 2015 Aug 27;58(16):6336-47. doi: 10.1021/jm5018913. Epub 2015 Apr 24.
3
Characterization of COR627 and COR628, two novel positive allosteric modulators of the GABA(B) receptor.鉴定 COR627 和 COR628，两种新型 GABA(B) 受体正变构调节剂。
J Pharmacol Exp Ther. 2012 Mar;340(3):529-38. doi: 10.1124/jpet.111.186460. Epub 2011 Nov 30.
4
Novel GABA(B) receptor positive modulators: a patent survey.新型 GABA(B) 受体正向变构调节剂：专利调查。
Expert Opin Ther Pat. 2010 Aug;20(8):1007-17. doi: 10.1517/13543776.2010.506480.
5
Reducing effect of the positive allosteric modulators of the GABA(B) receptor, CGP7930 and GS39783, on alcohol intake in alcohol-preferring rats.γ-氨基丁酸B型（GABA(B)）受体的正变构调节剂CGP7930和GS39783对偏爱酒精大鼠酒精摄入量的降低作用。
Eur J Pharmacol. 2005 Nov 21;525(1-3):105-11. doi: 10.1016/j.ejphar.2005.10.005. Epub 2005 Nov 14.
6
Anticonvulsant effects of structurally diverse GABA(B) positive allosteric modulators in the DBA/2J audiogenic seizure test: Comparison to baclofen and utility as a pharmacodynamic screening model.结构多样的γ-氨基丁酸B型（GABA(B)）正向变构调节剂在DBA/2J听源性癫痫发作试验中的抗惊厥作用：与巴氯芬的比较及作为药效学筛选模型的实用性
Neuropharmacology. 2016 Feb;101:358-69. doi: 10.1016/j.neuropharm.2015.10.009. Epub 2015 Oct 22.
7
Influence of positive allosteric modulators on GABA(B) receptor coupling in rat brain: a scintillation proximity assay characterisation of G protein subtypes.正构变构调节剂对大鼠脑内GABA(B)受体偶联的影响：G蛋白亚型的闪烁邻近分析表征
J Neurochem. 2008 Apr;105(2):308-23. doi: 10.1111/j.1471-4159.2007.05131.x. Epub 2007 Nov 16.
8
Selected amino acids, dipeptides and arylalkylamine derivatives do not act as allosteric modulators at GABAB receptors.选定的氨基酸、二肽和芳基烷基胺衍生物在GABAB受体上不作为变构调节剂起作用。
Eur J Pharmacol. 2004 Jan 12;483(2-3):147-53. doi: 10.1016/j.ejphar.2003.10.024.
9
Mechanisms of allosteric modulation at GABAB receptors by CGP7930 and GS39783: effects on affinities and efficacies of orthosteric ligands with distinct intrinsic properties.CGP7930和GS39783对GABAB受体变构调节的机制：对具有不同内在特性的正构配体亲和力和效能的影响。
Neuropharmacology. 2005 Mar;48(3):343-53. doi: 10.1016/j.neuropharm.2004.10.013. Epub 2005 Jan 25.
10
5-(N, N-Hexamethylene) amiloride is a GABA-A ρ1 receptor positive allosteric modulator.5-（N，N-六亚甲基）氨氯吡脒是一种GABA-A ρ1受体正向变构调节剂。
Channels (Austin). 2016 Nov;10(6):498-506. doi: 10.1080/19336950.2016.1207021. Epub 2016 Jul 1.
引用本文的文献
1
Allosteric Impact of the Variable Insert Loop in H1-Related (VHR) Phosphatase.变构环在 H1 相关（VHR）磷酸酶中的作用
Biochemistry. 2020 May 26;59(20):1896-1908. doi: 10.1021/acs.biochem.0c00245. Epub 2020 May 6.
本文引用的文献
1
Activation of the γ-Aminobutyric Acid Type B (GABA(B)) Receptor by Agonists and Positive Allosteric Modulators.激动剂和正变构调节剂对γ-氨基丁酸B型（GABA(B)）受体的激活
J Med Chem. 2015 Aug 27;58(16):6336-47. doi: 10.1021/jm5018913. Epub 2015 Apr 24.
2
GABAB receptors as a therapeutic strategy in substance use disorders: focus on positive allosteric modulators.γ-氨基丁酸B型（GABAB）受体作为物质使用障碍的一种治疗策略：聚焦于正变构调节剂。
Neuropharmacology. 2015 Jan;88:36-47. doi: 10.1016/j.neuropharm.2014.06.016. Epub 2014 Jun 24.
3
GABAB receptors: structure, functions, and clinical implications.GABAB受体：结构、功能及临床意义。
Neurology. 2012 Feb 21;78(8):578-84. doi: 10.1212/WNL.0b013e318247cd03.
4
GABA-B receptor: possible target for Parkinson's disease therapy.γ-氨基丁酸B受体：帕金森病治疗的潜在靶点。
Exp Neurol. 2012 Jan;233(1):121-2. doi: 10.1016/j.expneurol.2011.10.012. Epub 2011 Oct 25.
Zotero 插件